GlassScriptPhysician profile
Crystal D Reed
NPI 1588626576
$586.57
in general payments reported to CMS, 2019-2025
18 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.72 · 2023: $142 · 2024: $215 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $109.15 | 2019-2025 | Erleada, Rybrevant, Tecvayli |
| Emd Serono, INC. | $57.15 | 2024 | |
| Merck Sharp & Dohme LLC | $51.48 | 2023-2025 | Keytruda |
| Incyte Corporation | $47.34 | 2023 | Jakafi, Monjuvi, Pemazyre |
| Genentech USA, INC. | $46.14 | 2024-2025 | Itovebi, Alecensa, Tecentriq |
| Astrazeneca Pharmaceuticals LP | $31.55 | 2024 | |
| Aveo Pharmaceuticals, INC. | $31.15 | 2024 | |
| Abbvie INC. | $28.58 | 2025 | |
| Sumitomo Pharma America, INC. | $22.28 | 2025 | Orgovyx |
| Sobi, INC | $21.76 | 2024 | |
| Adc Therapeutics America, INC. | $20.16 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.71 | 2023 | |
| Eisai INC. | $18.04 | 2025 | |
| Iovance Biotherapeutics, INC. | $17.97 | 2025 | Amtagvi |
| Pharmaessentia USA Corporation | $17.52 | 2025 | Besremi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.97 | 2024 | Fruzaqla |
| Azurity Pharmaceuticals, INC. | $15.93 | 2025 | Danziten, Vivimusta |
| Springworks Therapeutics, INC. | $14.69 | 2025 | Gomekli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.